Black and Hispanic Patients Infected with the HIV virus are Less Likely than Whites

Black and Hispanic patients infected with the HIVThe research team studied a nationally representative
virus are less likely than whites to participate in clinicalsample of 2 864 adults in the 48 contiguous United
studies of new treatments or to receiveStates who were receiving care for HIV infection in
experimental drugs, according to the first study that1996. They interviewed participants three times
has used nationally representative data to examinebetween 1996 and 1998, asking about their
such disparities. Moreover, underrepresentation ofparticipation in studies, their use of experimental
blacks and Hispanics in HIV treatment studiesdrugs and other personal data, including such factors
becomes a concern for the applicability of the clinicalas their trust of doctors and desire to participate in
research to patients in the general population.decisions about treatment. The researchers found
The findings indicate that people with HIV infectionthat, in addition to being black or Hispanic, several
overall are much more likely to get experimentalother factors also reduced patients' likelihood of
treatments than are people with other diseases, suchparticipating in a clinical trial. They included having less
as cancer or heart disease. Because AIDS treatmentthan a high school education, belonging to a health
is evolving rapidly Links Of London and because themaintenance organization (HMO), and living eight or
virus often develops resistance to approved drugs,more miles from a major research hospital. Patients
AIDS activists have lobbied successfully to expandwho were white, who were highly educated or who
access to new medicines. An estimated 14 percentreceived their health care close to a research center
of the approximately 231 000 adults treated for HIVwere more likely than others to get experimental
infection in 1996 participated in a clinical trial, and 24drugs.
percent had taken an experimental drug, the studyIn an editorial accompanying the study, Tallmadge E.
found. Only 4 percent of adults with cancer who areKing of San Francisco General Hospital suggested that
less than 50 years old participate in clinical trials.racial and ethnic disparities in access to experimental
But the results suggest marked racial and ethnictreatment may reflect "barriers at the level of the
disparities in access to experimental HIV treatment.patient, the Links Of London Bracelets physician, the
Blacks made up only 23 percent of clinical studyinstitution and the community. "Doctors may harbor
participants but constituted 33 percent of adultsunconscious prejudices toward blacks or Hispanics, he
receiving HIV care. Similarly, 11 percent of studysuggested. Patients may be mistrustful or fear that
participants, but 15 percent of HIV-infected patientsparticipating in a study will threaten their autonomy.
nationally, were Hispanic. In contrast, whites made upResearchers studying new treatments for drug
62 percent of participants in HIV trials, yetcompanies may avoid enrolling members of minorities
represented only 49 percent of adults receiving HIV"because they believe that poor compliance is
care.common in these groups".